QQ客服 官方微博 反馈留言

	Erratum: Different efficacy of EGFR tyrosine kinase inhibitors and prognosis in patients with subtypes of EGFR-mutated advanced non-small cell lung cancer: a meta-analysis [J Cancer Res Clin Oncol, DOI 10.1007/s00432-014-1709-0]
	Wang, Huan/56195049000[0]; Huang, Jing/55442842800[1]; Yu, Xiaojin/36524621600[2]; Han, Shuhua/56195027400[3]; Yan, Xing/56194821300[4]; Sun, Siqing/55202966400[5]; Zhu, Xiaoli/55696701800[6]
刊名	Journal of Cancer Research and Clinical Oncology
	2014
卷号	140期号:11
ISSN号	0171-5216
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4877800
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Wang, Huan/56195049000[0],Huang, Jing/55442842800[1],Yu, Xiaojin/36524621600[2],et al. Erratum: Different efficacy of EGFR tyrosine kinase inhibitors and prognosis in patients with subtypes of EGFR-mutated advanced non-small cell lung cancer: a meta-analysis [J Cancer Res Clin Oncol, DOI 10.1007/s00432-014-1709-0][J]. Journal of Cancer Research and Clinical Oncology,2014,140(11).
APA	Wang, Huan/56195049000[0].,Huang, Jing/55442842800[1].,Yu, Xiaojin/36524621600[2].,Han, Shuhua/56195027400[3].,Yan, Xing/56194821300[4].,...&Zhu, Xiaoli/55696701800[6].(2014).Erratum: Different efficacy of EGFR tyrosine kinase inhibitors and prognosis in patients with subtypes of EGFR-mutated advanced non-small cell lung cancer: a meta-analysis [J Cancer Res Clin Oncol, DOI 10.1007/s00432-014-1709-0].Journal of Cancer Research and Clinical Oncology,140(11).
MLA	Wang, Huan/56195049000[0],et al."Erratum: Different efficacy of EGFR tyrosine kinase inhibitors and prognosis in patients with subtypes of EGFR-mutated advanced non-small cell lung cancer: a meta-analysis [J Cancer Res Clin Oncol, DOI 10.1007/s00432-014-1709-0]".Journal of Cancer Research and Clinical Oncology 140.11(2014).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。